Jesper Petersen

Jesper Petersen

Auto-generated profile, based on publicly available information

Jesper Petersen

Danish Red Blood Cell Centre, Department of Haematology, Copenhagen University Hospital – Rigshospitalet

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2024 in Blood
Verified
Journal Article
Closed access
PDF file
MMMathis Mottelson
Mathis Mottelson
Andreas GlenthøjAndreas Glenthøj
Andreas Glenthøj
BNBørge Grønne Nordestgaard
Børge Grønne Nordestgaard
CEChristina Ellervik
Christina Ellervik
JPJesper Brix Petersen
Jesper Brix Petersen
JHJens Helby
Jens Helby
It is unclear whether risk of infection is increased in individuals with hereditary hemochromatosis and in individuals with low or high plasma iron, transferrin saturation, or ferritin. Therefore, we tested whether high and low iron, transferrin saturation, and ferritin are associated with risk of infections observationally and genetically through HFE genotypes. We studied 142 188 Danish general population individuals. Iron, transferrin saturation, and ferritin were measured in 136 656, 136 599, and 38 020 individuals, respectively. HFE was genotyped for C282Y and H63D in 132 542 individuals. Median follow-up after study enrollment was 8 years (range, 0-38) for hospital and emergency room admissions with infections (n = 20 394) using the National Patient Register, covering all Danish hospitals. Hazard ratios for any infection were 1.20 (95% confidence interval [CI], 1.12-1.28) and 1.14 (95% CI, 1.07-1.22) in individuals with plasma iron ≤5th or ≥95th percentile compared with individuals with iron from 26th to 74th percentiles. Findings for transferrin saturation were similar, whereas infection risk was not increased in individuals with ferritin ≤5th or ≥95th percentile. Hazard ratios in C282Y homozygotes vs noncarriers were 1.40 (95% CI, 1.16-1.68) for any infection, 1.69 (95% CI, 1.05-2.73) for sepsis, and 2.34 (95% CI, 1.41-3.90) for death from infectious disease. Risk of infection was increased in C282Y homozygotes with normal plasma iron, transferrin saturation, or ferritin, and in C282Y homozygotes without liver disease, diabetes, and/or heart failure. In summary, low and high plasma iron and transferrin saturation were independently associated with increased infection risk. C282Y homozygotes had increased risk of any infection, sepsis, and death from infections. Even C282Y homozygotes with normal iron, transferrin saturation, or ferritin, not currently recommended for genotyping, had increased infection risk.

6 December 2007 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JPJesper Petersen
Jesper Petersen
LPLena Poulsen
Lena Poulsen
SPSarunas Petronis
Sarunas Petronis
HBHenrik Birgens
Henrik Birgens
MDMartin Dufva
Martin Dufva
DNA microarrays are generally operated at a single condition, which severely limits the freedom of designing probes for allele-specific hybridization assays. Here, we demonstrate a fluidic device for multi-stringency posthybridization washing of microarrays on microscope slides. This device is called a multi-thermal array washer (MTAW), and it has eight individually controlled heating zones, each of which corresponds to the location of a subarray on a slide. Allele-specific oligonucleotide probes for nine mutations in the beta-globin gene were spotted in eight identical subarrays at positions corresponding to the temperature zones of the MTAW. After hybridization with amplified patient material, the slides were mounted in the MTAW, and each subarray was exposed to different temperatures ranging from 22 to 40°C. When processed in the MTAW, probes selected without considering melting temperature resulted in improved genotyping compared with probes selected according to theoretical melting temperature and run under one condition. In conclusion, the MTAW is a versatile tool that can facilitate screening of a large number of probes for genotyping assays and can also enhance the performance of diagnostic arrays.

1 June 2013 in SLAS Technology
Verified
Journal Article
Open access
PDF file
DSDavid Sabourin
David Sabourin
PSPeder Skafte-Pedersen
Peder Skafte-Pedersen
MSMartin Jensen Søe
Martin Jensen Søe
MHMette Hemmingsen
Mette Hemmingsen
MAMassimo Alberti
Massimo Alberti
MDMartin Dufva
Martin Dufva
A microfluidic component library for building systems driving parallel or serial microfluidic-based assays is presented. The components are a miniaturized eight-channel peristaltic pump, an eight-channel valve, sample-to-waste liquid management, and interconnections. The library of components was tested by constructing various systems supporting perfusion cell culture, automated DNA hybridizations, and in situ hybridizations. The results showed that the MainSTREAM components provided (1) a rapid, robust, and simple method to establish numerous fluidic inputs and outputs to various types of reaction chips; (2) highly parallel pumping and routing/valving capability; (3) methods to interface pumps and chip-to-liquid management systems; (4) means to construct a portable system; (5) reconfigurability/flexibility in system design; (6) means to interface to microscopes; and (7) compatibility with tested biological methods. It was found that LEGO Mindstorms motors, controllers, and software were robust, inexpensive, and an accessible choice as compared with corresponding custom-made actuators. MainSTREAM systems could operate continuously for weeks without leaks, contamination, or system failures. In conclusion, the MainSTREAM components described here meet many of the demands on components for constructing and using microfluidics systems.

25 March 2010 in Biomedical Microdevices
Verified
Journal Article
Closed access
PDF file
DSDavid Sabourin
David Sabourin
JPJesper Petersen
Jesper Petersen
DSDetlef Snakenborg
Detlef Snakenborg
MBMonica Brivio
Monica Brivio
HGHaukur Gudnadson
Haukur Gudnadson
MDMartin Dufva
Martin Dufva

1 May 2006 in Analytical Biochemistry
Verified
Journal Article
Closed access
MDMartin Dufva
Martin Dufva
JPJesper Petersen
Jesper Petersen
MSMichael Stoltenborg
Michael Stoltenborg
HBHenrik Birgens
Henrik Birgens
CCClaus B.V. Christensen
Claus B.V. Christensen

27 September 2022 in American Journal of Hematology
Verified
Journal Article
Open access
ANAmina Nardo‐Marino
Amina Nardo‐Marino
Andreas GlenthøjAndreas Glenthøj
Andreas Glenthøj
JBJohn N. Brewin
John N. Brewin
JPJesper Petersen
Jesper Petersen
TBThomas H. Braunstein
Thomas H. Braunstein
DRDavid Rees
David Rees
It is well established that splenic dysfunction occurs in early childhood in sickle cell anemia (SCA), although the determinants and consequences of splenic injury are not fully understood. In this study, we examined spleen size and splenic function in 100 children with SCA aged 0–16 years at King's College Hospital in London. Spleen size was assessed by abdominal ultrasound (US) and splenic function by pitted red blood cells (PIT counts). In our cohort, 5.6% of children aged 6–10 years and 19.4% of children aged 11–16 years had no visible spleen on US (autosplenectomy). Splenomegaly was common in all age groups, with 28% of children overall having larger spleens than the average for their age. Only one child had a PIT count suggesting preserved splenic function. We found no correlation between hemoglobin F levels and spleen size, nor was there any difference in spleen size between children treated with or without hydroxyurea. Although there was a trend toward increased spleen length in children with co‐inherited α‐thalassemia, this did not reach statistical significance. Finally, we found a strong association between erythrocyte deformability measured with oxygen gradient ektacytometry, spleen size, and PIT counts. In conclusion, our results do not agree with the general perception that most children with SCA undergo autosplenectomy within the first decade of life and indicate that loss of erythrocyte deformability contributes to loss of splenic filtration capacity in SCA, as well as phenotypical variations in spleen size.